MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4

Liang‐jun Tao(Chifeng Municipal Hospital), Shiping Zhang(Nanjing University of Chinese Medicine)
Neoplasma
January 1, 2019
Cited by 57


Related Papers